After years of constant denial, it appears that in the draft policy, the government is finally ready to accept that there is a problem with the drugs that are manufactured and sold in India.

CHENNAI: Pharmaceutical major Strides Shasun, which has secured the US Food and Drug Administration’s approval for its three plants in Puducherry and Cuddalore, is facing trouble.

Price control of Oral Rehydration Salt (ORS), a life-saving intervention for diarrhoea, is mired in controversy as the company with the largest share in the ORS market has challenged the ceiling pr

Order of the National Green Tribunal in the matter of Selaqui International School Vs. Union of India & Others dated 25/07/2017 regarding discharge of toxic waste by the factories at the Pharma City, Selaqui, Dehradun into River Yamuna.

CHENNAI: A shortage of drugs has affected the state since July 1 when the Goods and Services Tax (GST) kicked in, with dealers and distributors uncertain over the taxation structure and facing soft

National Institute of Virology to receive Sun Pharma's drug molecules for testing against 3 diseases

Order of the National Green Tribunal in the matter of Dr. A. Kishan Rao & Ors. Vs. Union of India & Others dated 12/06/2017 regarding pollution caused by pharmaceutical industries in Telangana. The Applicant (Dr. A. Kishan Rao) is seeking clarification of the order passed by the Court by which grant of consent by the Board is subject to certain conditions.

Order of the National Green Tribunal in the matter of Sumitra Devi Vs. CPCB & Others dated 23/05/2017. This is with regard to an industry called M/s Shanti Drugs Pvt. Ltd. From the report of the Joint Inspection Team, it appears that this industry has been operating without the consent of the Board with effect from 1st December, 2014. The Joint Inspection Team has pointed out serious deficiencies in the working of this industry including need for a suitable effluent treatment system to be designed and approved by the Experts.

Natco Pharma has received environment clearance (EC) for its Rs 480 crore expansion project in Telangana that would generate 1,500 jobs.

Express concerns over the quality of generic drugs